- Language: English
- 182 Pages
- Published: July 2013
- Region: Global
Global Intravenous Solutions Market 2014-2018
- Published: November 2013
- Region: Global
- 65 Pages
The analysts forecasts the Global Intravenous Solutions market to grow with a CAGR of 7.88 percent for the period 2013–2018. Several driving factors and trends will contribute to this growth—all of which will be outlined in detail in this report.
These analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers, and challenges, and a number of other factors to provide the most accurate and detailed market research reports possible.
A more specific breakdown of this report’s content has been listed below.
Overview of market share and landscape for the following key geographies:
Overview and impact analysis of:
- 3 Market Drivers
- 3 Market Challenges
- 3 Market Trends
Market Shares and SWOT Analysis for these vendors:
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Hospira Inc.
Five Force Model Impact Analysis of:
- New Entrants
- Market Competition
Note: All of the segments above are supplemented with a combination of statistical data, graphical analysis, and verbal explanation.
After purchasing any of our reports, you can request a one hour meeting to discuss any questions you may have with our team of analysts. SHOW LESS READ MORE >
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Geographical Segmentation
07.1 Intravenous Solutions Market in the Americas
07.1.1 Market Size and Forecast
07.2 Intravenous Solutions Market in the EMEA Region
07.2.1 Market Size and Forecast
07.3 Intravenous Solutions Market in the APAC Region
07.3.1 Market Size and Forecast
08. Key Leading Countries
08.1 Key Leading Countries in the Americas
08.2 Key Leading Countries in the EMEA Region
08.3 Key Leading Countries in the APAC Region
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Market Share Analysis 2013
16.3 Other Prominent Vendors
17. Key Vendor Analysis
17.1 B. Braun Melsungen AG
17.1.1 Business Overview
17.1.2 Business Segmentation
17.1.3 Key Information
17.1.4 SWOT Analysis
17.2 Baxter International Inc.
17.2.1 Business Overview
17.2.2 Business Segmentation
17.2.3 Key Information
17.2.4 SWOT Analysis
17.3 Fresenius Kabi AG
17.3.1 Business Overview
17.3.2 Business Segmentation
17.3.3 Key Information
17.3.4 SWOT Analysis
17.4 Hospira Inc.
17.4.1 Business Overview
17.4.2 Business Segmentation
17.4.3 Key Information
17.4.4 SWOT Analysis
18. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Intravenous Solutions Market 2013-2018 (US$ billion)
Exhibit 3: Global Intravenous Solutions Market by Geographical Segmentation 2013
Exhibit 4: Intravenous Solutions Market in the Americas 2013-2018 (US$ billion)
Exhibit 5: Intravenous Solutions Market in the EMEA Region 2013-2018 (US$ billion)
Exhibit 6: Intravenous Solutions Market in the APAC Region 2013-2018 (US$ billion)
Exhibit 7: Global Intravenous Solutions Market by Vendor Segmentation 2013
Exhibit 8: Business Segmentation of B. Braun Melsungen AG
Exhibit 9: Business Segmentation of Baxter International Inc.
Exhibit 10: Business Segmentation of Fresenius Kabi AG
Exhibit 11: Business Segmentation of Hospira Inc.
Commenting on the report, an analyst from the team said: “Intravenous Vitamin C therapy has been shown to be effective against a wide variety of cancers. By intravenously injecting Vitamin C into a patient, it was observed that Ascorbate was able to generate a sufficient concentration of hydrogen peroxide and selectively kill cancer tissues through oxidative stress. Evidence has also been pointed out that a high dose of Vitamin C is very toxic for a variety of cancer cell lines. Six clinical trials testing Vitamin C, along with other chemotherapeutic drugs, are currently being conducted to determine their effectiveness in cancer treatment. If approved, the Vitamin C therapy delivered intravenously could be utilized to improve the quality of life for the patients afflicted with different types of cancer. Thus, the rising popularity of Vitamin C therapy administered intravenously, and its approval in clinical practice, could boost the growth of the overall Global Intravenous Solutions market during the forecast period.”
According to the report, the increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that is driving the growth of the Global Intravenous Solutions market. Nearly 100 million Americans are affected by gastrointestinal disorders each year, and more than 350 million people globally, as of 2012, are affected by diabetes. Hence, the increasing incidences of gastrointestinal disorders, cancer, and diabetes are expected to increase the rate of adoption of intravenous solutions among consumers, driving the growth of the Global Intravenous Solutions market.
Further, the report states that one of the main challenges hindering the growth of this market is the presence of stringent regulation policies. Stringent government regulations lead to unnecessary delays and additional costs in manufacturing for a company. The additional cost borne by the vendor is levied on the selling price of the intravenous solution, further hindering the adoption of intravenous solutions
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- Airwell Group
- Carrier Corp.
- Daikin Industries Ltd.
- Dwyer Instruments Inc.
- Gree Electric Appliances Inc.
- Haier Inc.
- Ingersoll-Rand plc
- Johnson Controls Inc.
- Lennox International Inc.
- LG Electronics Inc.
- Mitsubishi Electric Corp.
- Samsung Electronics Co. Ltd.
- Siemens AG
- Toshiba Corp.
- Voltas Ltd.
- Whirlpool Corp.